Hikal Limited reported a net loss of ₹22.4 crore for the quarter ended June 30, 2025 (Q1 FY26), compared to a net profit of ₹5.1 crore in the same quarter last year. The decline was driven by lower revenue and continued cost pressures.
The company’s total revenue from operations fell to ₹380.4 crore, down 6.5% from ₹406.8 crore reported in Q1 FY25. Sequentially, revenue also declined from ₹552.4 crore in Q4 FY25. Total income for the quarter stood at ₹381.4 crore, as compared to ₹407.3 crore a year ago and ₹552.9 crore in the previous quarter.
EBITDA for the quarter stood at ₹251 million, down sharply from ₹580 million in Q1 FY25. The EBITDA margin contracted to 6.6%, compared to 14.26% a year ago, reflecting pressure on both topline and profitability.
Expenses for the quarter remained elevated at ₹411.8 crore, largely driven by higher raw material costs (₹182 crore), employee expenses (₹62.9 crore), and other expenses (₹105.6 crore).
The company reported a pre-tax loss of ₹30.4 crore against a profit of ₹6.9 crore in Q1 FY25 and ₹68.3 crore in Q4 FY25. Tax reversal of ₹8 crore partially cushioned the loss, but it was not enough to offset the steep drop in operational performance.
Hikal’s management did not provide segmental updates in this disclosure, but margins appear compressed due to both volume and pricing pressures in the life sciences and chemical intermediates space.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
